# Survival of the Probiotic Lacticaseibacillus Paracasei Strain Shirota (LcS) in the GI Tract of Healthy Adults

> **NCT05522777** · NA · COMPLETED · sponsor: **Yakult U.S.A. Inc.** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Drink one bottle of Yakult a day

## Key facts

- **NCT ID:** NCT05522777
- **Lead sponsor:** Yakult U.S.A. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-15
- **Primary completion:** 2022-10-28
- **Final completion:** 2023-01-13
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-12-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05522777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05522777, "Survival of the Probiotic Lacticaseibacillus Paracasei Strain Shirota (LcS) in the GI Tract of Healthy Adults". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05522777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*